Cargando…

Predicting clinical progression in multiple sclerosis after 6 and 12 years

BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590122/ https://www.ncbi.nlm.nih.gov/pubmed/30629788 http://dx.doi.org/10.1111/ene.13904

Ejemplares similares

The sequence of structural, functional and cognitive changes in multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2020)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

A more unstable resting-state functional network in cognitively declining multiple sclerosis
por: Broeders, Tommy A. A., et al.
Publicado: (2022)

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis
por: Huiskamp, Marijn, et al.
Publicado: (2021)

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2017)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
por: Dekker, Iris, et al.
Publicado: (2019)

Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2022)

Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2020)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects
por: Weeda, M.M., et al.
Publicado: (2019)

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017)

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients
por: Bridel, Claire, et al.
Publicado: (2018)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study
por: Tewarie, Prejaas, et al.
Publicado: (2018)

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network
por: Nij Bijvank, J.A., et al.
Publicado: (2021)

The cerebellum and its network: Disrupted static and dynamic functional connectivity patterns and cognitive impairment in multiple sclerosis
por: Schoonheim, Menno M, et al.
Publicado: (2021)

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
por: Broos, Jelle Y., et al.
Publicado: (2023)

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis
por: Nauta, Ilse M, et al.
Publicado: (2020)

Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2020)

Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)

Network Collapse and Cognitive Impairment in Multiple Sclerosis
por: Schoonheim, Menno M., et al.
Publicado: (2015)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
por: Kilsdonk, Iris D, et al.
Publicado: (2017)

Cognitive Dysfunction in Early Multiple Sclerosis: Altered Centrality Derived from Resting-State Functional Connectivity Using Magneto-Encephalography
por: Hardmeier, Martin, et al.
Publicado: (2012)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
por: Loonstra, Floor C., et al.
Publicado: (2023)

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, J.A., et al.
Publicado: (2019)

Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR
por: Noteboom, Samantha, et al.
Publicado: (2023)

Progression of regional grey matter atrophy in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics
por: Schoonheim, Menno M., et al.
Publicado: (2022)

Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references
por: de Sitter, Alexandra, et al.
Publicado: (2021)

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
por: Nij Bijvank, Jenny, et al.
Publicado: (2022)

Structure‐function relationships in the visual system in multiple sclerosis: an MEG and OCT study
por: Tewarie, Prejaas, et al.
Publicado: (2017)

A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
por: Nij Bijvank, Jenny A, et al.
Publicado: (2022)

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
por: Coerver, Eline M. E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dk0h5hdmsngk07vcgaa05u18v0